New Jersey A 435: Limits upfront costs for oral anticancer medications for persons covered under certain health benefits plans.

Status: Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee (as of 2020-01-14)

State: New Jersey · Session: 219 · Bill: A 435

Subjects: DISEASE, PHARMACEUTIC

Sponsors: Catalano, John, McGuckin, Gregory P.

View New Jersey A 435 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.